Niagen Bioscience, Inc. current report, 12 February 2018

SEC Filing Summary: ChromaDex Corporation (8-K)

Business Context and Reporting Period

ChromaDex Corporation, a Delaware corporation, filed this Form 8-K on February 12, 2018. The filing serves to announce the company's expected, unaudited financial results for the fourth quarter and full year ended December 30, 2017. The registrant is identified as an emerging growth company.

Key Financial Metrics

The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It explicitly states that the company issued a press release containing these expected figures, which is attached as Exhibit 99.1. Consequently, no quantitative financial metrics can be extracted from the body of this 8-K document alone.

Material Changes

As the specific financial figures are contained in the attached press release rather than the 8-K text, the filing does not detail specific material changes versus prior periods. The filing indicates that the company is reporting its expected operating loss and revenue for the reported periods.

Guidance, Outlook, and Risks

The filing includes a standard disclaimer stating that the information furnished in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It is not subject to the liability of that section nor incorporated by reference in other filings, except as expressly set forth by specific reference. No specific forward-looking guidance or risk factors are detailed within the text of this 8-K.

Investor Verification Checklist

  • Review Exhibit 99.1 (Press Release dated February 12, 2018) for the specific unaudited revenue and operating loss figures.
  • Verify the company's status as an emerging growth company and any implications for financial reporting standards.
  • Confirm the fiscal year-end date of December 30, 2017, for accurate period comparison.
  • Note that the financial data in this filing is unaudited and furnished rather than formally filed under Section 18 liability.